News release
- HOME
- NEWS
-
- 2023.6.29
- President and CEO Misako Fujioka Interviewed in Newsweek International
-
- 2023.3.28
- Change in The Board of Directors
-
- 2023.3.15
- Notice of Launch of ALLYDONE® Patches 27.5 mg / ALLYDONE® Patches 55 mg in Japan as Japan’s First Donepezil Transdermal Therapeutic System
-
- 2022.12.23
- Manufacturing and Marketing Approval Received in Japan for ALLYDONE® Patches for Treatment of Dementia Due to Alzheimer’s Disease as Japan’s First Donepezil Transdermal Therapeutic System
-
- 2022.4.21
- Execution of a license agreement on an exclusive marketing right in Japan of the first donepezil transdermal therapeutic system in Japan
-
- 2020.7.3
- TEIKOKU SEIYAKU was selected as A Global Niche Top Company by METI in FY2020.
-
- 2020.3.27
- Change in The Board of Directors
-
- 2017.11.22
- Notice Launch of Rupafin® tablets in Japan
-
- 2017.9.27
- Notice regarding acquisition of manufacturing and sales approval for Rupafin® tablets
-
- 2016.10.4
- Execution of Basic Agreement for Sales Anti-Allergy Agent, Rupatadine Tablets